Literature DB >> 33800349

Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection.

Hye Suk Hwang1,2,3, Young-Tae Lee3, Ki-Hye Kim3, Ho Seong Seo4, Kap Seung Yang1,5, Hoonsung Cho1,2, Sang-Moo Kang3.   

Abstract

The roles of the Fc receptor (FcR) in protection or inflammatory disease after respiratory syncytial virus (RSV) vaccination and infection remain unknown. Virus-like particles containing RSV fusion proteins (RSV F-VLPs) induce T-helper type 1 antibody responses and protection against RSV. Heterologous RSV F-VLP prime and formalin-inactivated RSV (FI-RSV) boost vaccination has been reported to be effective in providing protection without inflammatory disease. Here, we investigated whether the FcRγ-chain is important for immune protection by the heterologous F-VLP and FI-RSV vaccination using FcRγ-chain knockout (-/-) mice. RSV F-VLP-primed and FI-RSV-boosted FcRγ -/- mice displayed less protective efficacy, as shown by higher lung viral titers upon RSV challenge, compared to RSV F-VLP-primed and FI-RSV-boosted immunized wild-type mice. RSV F-VLP and FI-RSV immunization induced lower levels of neutralizing activity and interferon-γ-producing CD8 T-cells in the bronchoalveolar lavage cells of FcRγ -/- mice than in those of wild-type mice. In addition, FcRγ -/- mice displayed a trend of enhancing lung histopathology after RSV vaccination and infection. This study suggests that the FcRγ-chain plays an important role in inducing antiviral protection and CD8 T-cell responses in RSV F-VLP prime and FI-RSV boost vaccination after RSV infections.

Entities:  

Keywords:  Fc receptor; RSV F-virus-like particles; cytotoxic T-cells

Year:  2021        PMID: 33800349      PMCID: PMC7998258          DOI: 10.3390/vaccines9030232

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  53 in total

Review 1.  Viral modulation of NK cell immunity.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Nat Rev Microbiol       Date:  2005-01       Impact factor: 60.633

2.  Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.

Authors:  Fu-Shi Quan; Yonghwan Kim; Sujin Lee; Hong Yi; Sang-Moo Kang; Jadranka Bozja; Martin L Moore; Richard W Compans
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

3.  Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.

Authors:  Stephanie J Win; Vernon K Ward; P Rod Dunbar; Sarah L Young; Margaret A Baird
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

4.  Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.

Authors:  Min-Chul Kim; Yu-Na Lee; Eun-Ju Ko; Jong Seok Lee; Young-Man Kwon; Hye Suk Hwang; Jae-Min Song; Byung-Min Song; Youn-Jeong Lee; Jun-Gu Choi; Hyun-Mi Kang; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang
Journal:  Mol Ther       Date:  2014-03-04       Impact factor: 11.454

5.  Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line.

Authors:  M J Cannon; C R Bangham
Journal:  J Gen Virol       Date:  1989-01       Impact factor: 3.891

6.  Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.

Authors:  Lori W McGinnes; Kathryn A Gravel; Robert W Finberg; Evelyn A Kurt-Jones; Michael J Massare; Gale Smith; Madelyn R Schmidt; Trudy G Morrison
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

7.  Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.

Authors:  B S Graham; G S Henderson; Y W Tang; X Lu; K M Neuzil; D G Colley
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

8.  Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.

Authors:  Eun-Ju Ko; Young-Man Kwon; Jong Seok Lee; Hye Suk Hwang; Si-Eun Yoo; Yu-Na Lee; Young-Tae Lee; Min-Chul Kim; Min Kyoung Cho; You Ri Lee; Fu-Shi Quan; Jae-Min Song; Sujin Lee; Martin L Moore; Sang-Moo Kang
Journal:  Nanomedicine       Date:  2014-08-08       Impact factor: 5.307

Review 9.  Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.

Authors:  Jop Jans; Marloes Vissers; Jacco G M Heldens; Marien I de Jonge; Ofer Levy; Gerben Ferwerda
Journal:  Rev Med Virol       Date:  2013-11-14       Impact factor: 6.989

10.  Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.

Authors:  Emily A Hemann; Sang-Moo Kang; Kevin L Legge
Journal:  J Immunol       Date:  2013-07-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.